Tag Archives: Study

Study of injectable PrEP reports the best efficacy seen yet for any form of PrEP in women

HPTN 084 study finds significantly lower adherence in women taking daily PrEP pills A second study of an injectable HIV drug used to prevent HIV has had its randomised phase stopped early after it became clear that giving women a two-monthly injection of a prevention drug resulted in nearly nine times fewer infections than giving… Read More »

Coronavirus has infected 1.7 million New Yorkers, study estimates

An estimated 1.7 million New Yorkers have had COVID-19 — six times the official count, a study released Tuesday suggests. Researchers from the Icahn School of Medicine at Mount Sinai also found the coronavirus was circulating through the five boroughs “long before” the first recorded case, the study published in Nature states. An estimated 1.7 million New Yorkers have had… Read More »

Crispr Gene Editing Can Cause Unwanted Changes in Human Embryos, Study Finds

A powerful gene-editing tool called Crispr-Cas9, which this month nabbed the Nobel Prize in Chemistry for two female scientists, can cause serious side effects in the cells of human embryos, prompting them to discard large chunks of their genetic material, a new study has found. Administered to cells to repair a mutation that can cause… Read More »

Severe morning sickness linked to depression new study finds

Severe morning sickness increases the risk of depression both during and after pregnancy, new research has found. Severe morning sickness, known as hyperemesis gravidarum (HG), is a debilitating condition that affects around 1-2 per cent of pregnant women in the UK. Far more serious than ‘normal’ morning sickness, it is one of the most common… Read More »

Pfizer’s Ibrance kisses early breast cancer hopes goodbye with second study failure

After Pfizer’s Ibrance failed a crucial study in HR-positive, HR-negative postsurgery breast cancer patients, the company clung to hope that it could still show a benefit in a high-risk subset of those patients. But new data have officially snuffed out those hopes. There’s “no saving adjuvant for Ibrance,” SVB Leerink analyst Geoffrey Porges wrote in… Read More »